| Literature DB >> 22970313 |
Angela B Bosman1, Jaap A Wagenaar, Jaap Wagenaar, Arjan Stegeman, Hans Vernooij, Dik Mevius.
Abstract
This study was performed to determine a sampling strategy to quantify the prevalence of antimicrobial resistance on veal calf farms, based on the variation in antimicrobial resistance within and between calves on five farms. Faecal samples from 50 healthy calves (10 calves/farm) were collected. From each individual sample and one pooled faecal sample per farm, 90 selected Escherichia coli isolates were tested for their resistance against 25 mg/L amoxicillin, 25 mg/L tetracycline, 0.5 mg/L cefotaxime, 0.125 mg/L ciprofloxacin and 8/152 mg/L trimethoprim/sulfamethoxazole (tmp/s) by replica plating. From each faecal sample another 10 selected E. coli isolates were tested for their resistance by broth microdilution as a reference. Logistic regression analysis was performed to compare the odds of testing an isolate resistant between both test methods (replica plating vs. broth microdilution) and to evaluate the effect of pooling faecal samples. Bootstrap analysis was used to investigate the precision of the estimated prevalence of resistance to each antimicrobial obtained by several simulated sampling strategies. Replica plating showed similar odds of E. coli isolates tested resistant compared to broth microdilution, except for ciprofloxacin (OR 0.29, p ≤ 0.05). Pooled samples showed in general lower odds of an isolate being resistant compared to individual samples, although these differences were not significant. Bootstrap analysis showed that within each antimicrobial the various compositions of a pooled sample provided consistent estimates for the mean proportion of resistant isolates. Sampling strategies should be based on the variation in resistance among isolates within faecal samples and between faecal samples, which may vary by antimicrobial. In our study, the optimal sampling strategy from the perspective of precision of the estimated levels of resistance and practicality consists of a pooled faecal sample from 20 individual animals, of which 90 isolates are tested for their susceptibility by replica plating.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22970313 PMCID: PMC3436765 DOI: 10.1371/journal.pone.0044831
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Farm characteristics of the five selected veal calf farms.
| # Calves | # Barns | Oral group medication | |
| Farm 1 | 416 | 3 | Oxytetracycline-HCl, Colistin, Doxycycline |
| Farm 2 | 1030 | 2 | Oxytetracycline-HCl, Colistin, Ampicillin |
| Farm 3 | 1335 | 2 | Oxytetracycline-HCl, Colistin, Tylosin |
| Farm 4 | 190 | 1 | Oxytetracycline-HCl, Colistin, Ampicillin |
| Farm 5 | 898 | 3 | Oxytetracycline-HCl, Colistin |
Distribution of farm sizes in The Netherlands (n = 2064): 53% <450 veal calves/farm, 22% 450–750 veal calves/farm, 25% >750 veal calves/farm.
Logistic regression analysis of explanatory variables test method and sample type including their interaction with the tested antimicrobials on the odds of resistant isolates in faecal samples.
| Variable |
| SE( |
| OR | 95% CI | ||
| Lower | Upper | ||||||
| Test method | Broth microdilution | Reference | 1 | ||||
| Replica plating - Amox | 0.20 | 0.11 | 0.07 | 1.23 | 0.98 | 1.53 | |
| Replica plating - Cip | −1.23 | 0.14 | <2e-16 | 0.29 | 0.22 | 0.38 | |
| Replica plating - Tet | 0.23 | 0.18 | 0.19 | 1.26 | 0.89 | 1.79 | |
| Replica plating - Tmp/s | 0.12 | 0.11 | 0.31 | 1.12 | 0.90 | 1.40 | |
| Sample type | Individual sample | Reference | 1 | ||||
| Pooled sample - Amox | −0.56 | 0.62 | 0.36 | 0.57 | 0.17 | 1.91 | |
| Pooled sample - Cip | −0.65 | 0.64 | 0.31 | 0.52 | 0.15 | 1.84 | |
| Pooled sample - Tet | 0.19 | 0.64 | 0.77 | 1.21 | 0.34 | 4.27 | |
| Pooled sample - Tmp/s | −0.26 | 0.62 | 0.68 | 0.77 | 0.23 | 2.59 | |
Amox = amoxicilline, Cip = ciprofloxacine, Tet = tetracycline, Tmp/s = trimethoprim/sulfa-methoxazole.
Variance random sample effect = 1.561.
Variance random pen effect = 0.084.
Variance random farm effect = 1.413.
Proportions and numbers of E. coli isolates tested resistant by replica plating and broth microdilution in individual and pooled samples.
| Individual samples | Pooled samples | |||
| RP | BMD | RP | BMD | |
| Antimicrobial | (n = 4320) | (n = 500) | (n = 450) | (n = 50) |
| Amoxicillin | 0.61 (n = 2652) | 0.57 (n = 287) | 0.50 (n = 225) | 0.54 (n = 27) |
| Cefotaxime | 0.02 (n = 83) | 0 (n = 0) | 0.004 (n = 2) | 0 (n = 0) |
| Ciprofloxacin | 0.11 (n = 475) | 0.23 (n = 114) | 0.06 (n = 28) | 0.14 (n = 7) |
| Tetracycline | 0.92 (n = 3963) | 0.91 (n = 453) | 0.95 (n = 427) | 0.92 (n = 46) |
| Trimethoprim - sulfamethoxazole | 0.47 (n = 2015) | 0.44 (n = 220) | 0.40 (n = 182) | 0.44 (n = 22) |
RP = Replica plating test method. BMD = Broth microdilution test method.
MIC distribution of 500 E. coli isolates (in %) tested for their antimicrobial susceptibility to ampicillin, tetracycline, cefotaxime, ciprofloxacin, trimethoprim and sulphamethoxazole by broth microdilution.
| E. coli | MIC distribution mg/L (%) | ||||||||||||||||||
| N = 500 | 0 | 0.015 | 0.03 | 0.06 | 0.125 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 | 128 | 256 | 512 | 1024 | 2048 |
| Ampicillin | 0 | 0.2 | 8.2 | 30.6 | 3.6 | 0 | 0 | 57.4 | |||||||||||
| Tetracycline | 0.2 | 3.6 | 5.2 | 0.4 | 0 | 0.2 | 10.4 | 80 | |||||||||||
| Cefotaxime | 58.8 | 37.8 | 3.4 | 0 | 0 | ||||||||||||||
| Ciprofloxacin | 0.4 | 34 | 42.8 | 7.8 | 4.2 | 9 | 0.8 | 0 | 0 | 0 | 0.4 | 0.6 | |||||||
| Trimethoprim | 50.6 | 2.6 | 0.2 | 0 | 0 | 0 | 1.4 | 45.2 | |||||||||||
| Sulfamethoxazole | 45.4 | 1 | 0 | 0 | 0.2 | 0 | 0 | 0.8 | 52.6 | ||||||||||
Proportion E. coli isolates resistant to amoxicillin (25 mg/L), tetracycline (25 mg/L), ciprofloxacin (0.125 mg/L) and trimethoprim/sulfamethoxazole (8/152 mg/L) obtained with 8 different sampling strategies.
| Precision | ||||||
| # Isolates | Total number | 2.5th–97.5th | ||||
| Strategy | # Samples | per sample | of isolates | Mean | S.D. | Percentiles |
| Proportion of | ||||||
| 1 | 4 | 5 | 20 | 0.61 | 0.06 | 0.50–0.73 |
| 2 | 5 | 4 | 20 | 0.61 | 0.06 | 0.51–0.72 |
| 3 | 10 | 2 | 20 | 0.61 | 0.05 | 0.52–0.70 |
| 4 | 10 | 4 | 40 | 0.61 | 0.04 | 0.54–0.69 |
| 5 | 20 | 2 | 40 | 0.61 | 0.03 | 0.55–0.68 |
| 6 | 5 | 20 | 100 | 0.61 | 0.04 | 0.53–0.70 |
| 7 | 10 | 10 | 100 | 0.61 | 0.03 | 0.55–0.68 |
| 8 | 20 | 5 | 100 | 0.61 | 0.03 | 0.56–0.66 |
| Proportion of | ||||||
| 1 | 4 | 5 | 20 | 0.92 | 0.04 | 0.82–0.98 |
| 2 | 5 | 4 | 20 | 0.92 | 0.04 | 0.83–0.98 |
| 3 | 10 | 2 | 20 | 0.92 | 0.03 | 0.85–0.98 |
| 4 | 10 | 4 | 40 | 0.92 | 0.03 | 0.86–0.96 |
| 5 | 20 | 2 | 40 | 0.92 | 0.02 | 0.87–0.96 |
| 6 | 5 | 20 | 100 | 0.92 | 0.03 | 0.85–0.97 |
| 7 | 10 | 10 | 100 | 0.92 | 0.02 | 0.87–0.96 |
| 8 | 20 | 5 | 100 | 0.92 | 0.03 | 0.85–0.97 |
| Proportion of | ||||||
| 1 | 4 | 5 | 20 | 0.11 | 0.05 | 0.03–0.21 |
| 2 | 5 | 4 | 20 | 0.11 | 0.04 | 0.03–0.20 |
| 3 | 10 | 2 | 20 | 0.11 | 0.03 | 0.05–0.18 |
| 4 | 10 | 4 | 40 | 0.11 | 0.03 | 0.05–0.17 |
| 5 | 20 | 2 | 40 | 0.11 | 0.02 | 0.06–0.16 |
| 6 | 5 | 20 | 100 | 0.11 | 0.04 | 0.04–0.19 |
| 7 | 10 | 10 | 100 | 0.11 | 0.03 | 0.06–0.17 |
| 8 | 20 | 5 | 100 | 0.11 | 0.02 | 0.07–0.15 |
| Proportion of | ||||||
| 1 | 4 | 5 | 20 | 0.46 | 0.06 | 0.36–0.58 |
| 2 | 5 | 4 | 20 | 0.47 | 0.05 | 0.36–0.58 |
| 3 | 10 | 2 | 20 | 0.47 | 0.05 | 0.38–0.55 |
| 4 | 10 | 4 | 40 | 0.47 | 0.04 | 0.40–0.54 |
| 5 | 20 | 2 | 40 | 0.46 | 0.03 | 0.40–0.53 |
| 6 | 5 | 20 | 100 | 0.46 | 0.04 | 0.39–0.55 |
| 7 | 10 | 10 | 100 | 0.47 | 0.03 | 0.40–0.53 |
| 8 | 20 | 5 | 100 | 0.47 | 0.03 | 0.42–0.52 |
using bootstrap resampling.